Front > Daily > Markets


Tue: TASE rebounds but coronavirus concerns remain

Teva and Perrigo led the rises today while Delek and Nice Systems led the declines.

Mon: Coronavirus pushes TASE to more steep losses

Delek and Harel led the market's continued slide but Perrigo again bucked the market.

Teva Teva digital asthma inhaler wins FDA nod

The ArmonAir Digihaler is for the treatment of asthma in patients 12 years and older.

Acro Tower  / Imagin: Studio 84 Fattal's Rooms leases shared workspace in Acro Tel Aviv tower

Rooms has signed a lease agreement for three floors covering 4,500 square meters.

El Al cargo plane  / Photo: Michal Raz-Chaimovich, Globes El Al hikes cargo prices

El Al: Prices are affected by foreign airlines on which we transship.

Biotech development, photo: Shutterstock Drug developer PolyPid to file for Wall Street IPO

The company raised $50 million six months ago from its existing shareholders, and has now raised a total of $105 million.

Shai Novik Photo: Eyal Yitzhar Israel's Enlivex reports drug could help COVID-19 patients

Enlivex Therapeutics is increasing production of Allocetra, for treating patients with multisystem failure.

Prof. Amir Yaron Despite slowdown concerns, Bol keeps rate unchanged

Bank of Israel: It will be necessary to leave the interest rate at its current level for a prolonged period or to reduce it.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018